Julian Wilkins has over 30 years of professional experience in architecture and containment solutions for the pharmaceutical industry.  He has designed and managed the manufacture and qualification of containment systems for potent and aseptic compounds.


In 1991 he co-founded a pharmaceutical isolator company in the UK and in 1999 founded PharmaConsult US, a consulting company that is dedicated to controlling product and people exposure in the pharmaceutical and biotech industries.


Wilkins understands all aspects of Risk, Hazard and Exposure of People and Patients in the Pharmaceutical Industry, with particular emphasis on Exposure Control measures.  Julian has assisted many clients in assessing their risk of cross contamination and operator exposure.  From these risk assessments plan of actions are developed to assure that the high risk areas are addressed while the low risk areas are identified they are not given the same priority or resource as the high risk areas.

Publications include: A Technical Review of Isolators; Isolator Technology, Applications in the Pharmaceutical and Biotechnology Industries; Good Design Practices for GMP Pharmaceutical Facilities; and ISPE Risk-MaPP Baseline Guide©

Wilkins has a degree in Architecture from the Oxford School of Architecture.